With further news on patient tests not far away the upside is massive. Ron’s confirmation as per CEO master class interview, “ nothing in the space comparable” the nominal shares available, plenty of better days ahead.The NAN experience puts us in a good place in future negotiations.
With further news on patient tests not far away the upside is...
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.20 |
Change
-0.060(2.65%) |
Mkt cap ! $187.9M | |||
| Open | High | Low | Value | Volume |
| $2.25 | $2.25 | $2.20 | $132.3K | 59.91K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1518 | $2.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.25 | 3506 | 2 |
View Market Depth
| Last trade - 15.58pm 25/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.23 |
Change
-0.060 ( 0.79 %) |
||||
| Open | High | Low | Volume | ||
| $2.22 | $2.23 | $2.19 | 13210 | ||
| Last updated 15.58pm 25/04/2024 ? | |||||
| EMV (ASX) Chart |